Current opioid overdose crisis: Some comments on the chemicobiological aspects of tolerance/dependence and abuse based on computatinal chemistry and biology

Subhash C Basak; Lemont B. Kier

doi:10.2174/157340991403180727103859

Current opioid overdose crisis: Some comments on the chemicobiological aspects of tolerance/dependence and abuse based on computatinal chemistry and biology

Subhash C Basak, Lemont B. Kier

Natural Resources Research Institute

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	175-177
Number of pages	3
Journal	Current computer-aided drug design
Volume	14
Issue number	3
DOIs	https://doi.org/10.2174/157340991403180727103859
State	Published - Jan 1 2018

PubMed: MeSH publication types

Editorial

Access

10.2174/157340991403180727103859

Cite this

@article{16809bc371214c1cb119443a2fb96fec,

title = "Current opioid overdose crisis: Some comments on the chemicobiological aspects of tolerance/dependence and abuse based on computatinal chemistry and biology",

author = "Basak, {Subhash C} and Kier, {Lemont B.}",

year = "2018",

month = jan,

day = "1",

doi = "10.2174/157340991403180727103859",

language = "English (US)",

volume = "14",

pages = "175--177",

journal = "Current Computer-Aided Drug Design",

issn = "1573-4099",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - Current opioid overdose crisis

T2 - Some comments on the chemicobiological aspects of tolerance/dependence and abuse based on computatinal chemistry and biology

AU - Basak, Subhash C

AU - Kier, Lemont B.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85051711373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051711373&partnerID=8YFLogxK

U2 - 10.2174/157340991403180727103859

DO - 10.2174/157340991403180727103859

M3 - Editorial

C2 - 30062955

AN - SCOPUS:85051711373

VL - 14

SP - 175

EP - 177

JO - Current Computer-Aided Drug Design

JF - Current Computer-Aided Drug Design

SN - 1573-4099

IS - 3

ER -